Publicaciones en las que colabora con Alberto Ortiz Arduan (10)

2023

  1. BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease

    Antioxidants, Vol. 12, Núm. 5

  2. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis

    Pharmaceuticals, Vol. 15, Núm. 2

2017

  1. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage

    Journal of the American Society of Nephrology, Vol. 28, Núm. 2, pp. 504-519

2015

  1. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Human Immunology, Vol. 76, Núm. 2-3, pp. 75-78

2013

  1. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells

    Epigenetics, Vol. 8, Núm. 1, pp. 66-78

  2. The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

    Laboratory Investigation, Vol. 93, Núm. 7, pp. 812-824

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB

    Journal of the American Society of Nephrology, Vol. 22, Núm. 7, pp. 1315-1325

2010

  1. Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy

    Biochemical and Biophysical Research Communications, Vol. 397, Núm. 3, pp. 576-579